Stay updated on Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.

Latest updates to the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page
- Check5 days agoChange DetectedThe page now credits additional related resource sections (including “Idiopathic Pulmonary Fibrosis” and the Genetic and Rare Diseases Information Center). It also reflects an updated site revision/version number without changing the underlying clinical study information.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoChange DetectedPadova, Italy, 35128 was added to the study locations and Padua, Italy, 35128 was removed.SummaryDifference0.0%

- Check33 days agoChange DetectedRemoved the 'Interstitial lung disease 2' entry and the Genetic and Rare Diseases Information Center resource from the page. These items are auxiliary and do not affect the presentation of the trial details.SummaryDifference0.1%

- Check41 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0, indicating a maintenance/UI update without changes to study details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.